|
Market Closed -
Euronext Paris
11:55:00 2026-09-15 EDT
|
5-day change | 1st Jan Change | ||
| 1.080 EUR | -57.06% |
|
-62.50% | -77.55% |
| 09-15 | MaaT Pharma Gets EU Medicines Agency Panel's Negative Trend Vote on Xervyteg Re-examination | MT |
| 09-15 | Analysts grow concerned about MaaT Pharma |  |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Stocks
- MAAT Stock
- Consensus MaaT Pharma
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
